Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Brazilian generics market change after Farmácia Popular program.

Bertoldi AD, Chaves LA, Ross-Degnan D, Luiza VL, Emmerick ICM, Silva RMD, Campos MR.

Rev Saude Publica. 2019 Oct 17;53:94. doi: 10.11606/s1518-8787.2019053001237. eCollection 2019.

2.

Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal study.

Chang J, Xu S, Zhu S, Li Z, Yu J, Zhang Y, Zu J, Fang Y, Ross-Degnan D.

Lancet Infect Dis. 2019 Oct 3. pii: S1473-3099(19)30324-X. doi: 10.1016/S1473-3099(19)30324-X. [Epub ahead of print] Erratum in: Lancet Infect Dis. 2019 Oct 15;:.

PMID:
31588042
3.

Risk Factors Associated With Food Insecurity in the Medicare Population.

Madden JM, Shetty PS, Zhang F, Briesacher BA, Ross-Degnan D, Soumerai SB, Galbraith AA.

JAMA Intern Med. 2019 Sep 30. doi: 10.1001/jamainternmed.2019.3900. [Epub ahead of print] No abstract available.

PMID:
31566656
4.

Using a Social Worker Transition Coach to Improve Hospital-to-Home Transitions for High-Risk Nonelderly Patients.

Balaban R, Batalden M, Ross-Degnan D, Le Cook B.

J Healthc Qual. 2019 Aug 22. doi: 10.1097/JHQ.0000000000000219. [Epub ahead of print]

PMID:
31453829
5.

The Brazilian private pharmaceutical market after the first ten years of the generics law.

Bertoldi AD, Wagner AK, Emmerick ICM, Chaves LA, Stephens P, Ross-Degnan D.

J Pharm Policy Pract. 2019 Aug 14;12:18. doi: 10.1186/s40545-019-0179-9. eCollection 2019.

6.

Comparative Effectiveness of Vertical Sleeve Gastrectomy Versus Roux en y Gastric Bypass for Diabetes Treatment: A Claims-based Cohort Study.

Lewis KH, Arterburn DE, Zhang F, Callaway K, Wallace J, Fernandez A, Ross-Degnan D, Wharam JF.

Ann Surg. 2019 Jun 12. doi: 10.1097/SLA.0000000000003391. [Epub ahead of print]

PMID:
31205064
7.

A systematic review of the effectiveness of strategies to improve health care provider performance in low- and middle-income countries: Methods and descriptive results.

Rowe SY, Peters DH, Holloway KA, Chalker J, Ross-Degnan D, Rowe AK.

PLoS One. 2019 May 31;14(5):e0217617. doi: 10.1371/journal.pone.0217617. eCollection 2019.

8.

Uptake and use of a diabetes management program with a mobile glucometer.

Garabedian LF, Ross-Degnan D, LeCates RF, Wharam JF.

Prim Care Diabetes. 2019 Dec;13(6):549-555. doi: 10.1016/j.pcd.2019.03.010. Epub 2019 May 13.

PMID:
31097343
9.

Vulnerable And Less Vulnerable Women In High-Deductible Health Plans Experienced Delayed Breast Cancer Care.

Wharam JF, Zhang F, Wallace J, Lu C, Earle C, Soumerai SB, Nekhlyudov L, Ross-Degnan D.

Health Aff (Millwood). 2019 Mar;38(3):408-415. doi: 10.1377/hlthaff.2018.05026.

PMID:
30830830
10.

Contraceptive Initiation Among Women in the United States: Timing, Methods Used, and Pregnancy Outcomes.

Murray Horwitz ME, Ross-Degnan D, Pace LE.

Pediatrics. 2019 Feb;143(2). pii: e20182463. doi: 10.1542/peds.2018-2463. Epub 2019 Jan 15.

PMID:
30647089
11.

High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes.

Wharam JF, Lu CY, Zhang F, Callahan M, Xu X, Wallace J, Soumerai S, Ross-Degnan D, Newhouse JP.

Ann Intern Med. 2018 Dec 18;169(12):845-854. doi: 10.7326/M17-3365. Epub 2018 Nov 20.

PMID:
30458499
12.

Advancing Health Policy and Program Research in Diabetes: Findings from the Natural Experiments for Translation in Diabetes (NEXT-D) Network.

Ali MK, Wharam F, Kenrik Duru O, Schmittdiel J, Ackermann RT, Albu J, Ross-Degnan D, Hunter CM, Mangione C, Gregg EW; NEXT-D Study Group.

Curr Diab Rep. 2018 Nov 20;18(12):146. doi: 10.1007/s11892-018-1112-3. Review.

PMID:
30456479
13.

Trends and Disparities in Sexual and Reproductive Health Behaviors and Service Use Among Young Adult Women (Aged 18-25 Years) in the United States, 2002-2015.

Murray Horwitz ME, Pace LE, Ross-Degnan D.

Am J Public Health. 2018 Nov;108(S4):S336-S343. doi: 10.2105/AJPH.2018.304556.

14.

Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review.

Rowe AK, Rowe SY, Peters DH, Holloway KA, Chalker J, Ross-Degnan D.

Lancet Glob Health. 2018 Nov;6(11):e1163-e1175. doi: 10.1016/S2214-109X(18)30398-X. Epub 2018 Oct 8.

15.

Provider Perspectives on Quality Payment Programs Targeting Diabetes in Primary Care Settings.

Garabedian LF, Ross-Degnan D, Wharam JF.

Popul Health Manag. 2019 Jun;22(3):248-254. doi: 10.1089/pop.2018.0093. Epub 2018 Sep 11.

PMID:
30204544
16.

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China.

Guan X, Tian Y, Ross-Degnan D, Man C, Shi L.

BMJ Open. 2018 Jul 16;8(7):e022328. doi: 10.1136/bmjopen-2018-022328.

17.

Article 2: Longitudinal study assessing the one-year effects of supervision performance assessment and recognition strategy (SPARS) to improve medicines management in Uganda health facilities.

Trap B, Musoke R, Kirunda A, Oteba MO, Embrey M, Ross-Degnan D.

J Pharm Policy Pract. 2018 Jul 5;11:15. doi: 10.1186/s40545-018-0142-1. eCollection 2018.

18.

Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices.

Garabedian LF, Sinaiko AD, Ross-Degnan D, Abu-Jaber T, Hoefer M, Oddleifson S, Wagner AK.

Qual Manag Health Care. 2018 Jul/Sep;27(3):157-164. doi: 10.1097/QMH.0000000000000179.

PMID:
29944628
19.

Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.

Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L, Ross-Degnan D, Wharam JF.

Breast Cancer Res Treat. 2018 Sep;171(2):449-459. doi: 10.1007/s10549-018-4819-6. Epub 2018 Jun 1.

20.

Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.

Lu CY, Zhang F, Wagner AK, Nekhlyudov L, Earle CC, Callahan M, LeCates R, Xu X, Ross-Degnan D, Wharam JF.

Breast Cancer Res Treat. 2018 Aug;171(1):235-242. doi: 10.1007/s10549-018-4821-z. Epub 2018 May 12.

21.

Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil.

Luiza VL, Chaves LA, Campos MR, Bertoldi AD, Silva RM, Bigdeli M, Ross-Degnan D, Emmerick ICM.

BMJ Glob Health. 2018 Feb 7;2(Suppl 3):e000547. doi: 10.1136/bmjgh-2017-000547. eCollection 2017. Review.

22.

Drivers of Low-Value Care-Reply.

Hong AS, Ross-Degnan D, Wharam JF.

JAMA Intern Med. 2018 Mar 1;178(3):433-434. doi: 10.1001/jamainternmed.2017.8537. No abstract available.

PMID:
29507990
23.

Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.

Wharam JF, Zhang F, Lu CY, Wagner AK, Nekhlyudov L, Earle CC, Soumerai SB, Ross-Degnan D.

J Clin Oncol. 2018 Apr 10;36(11):1121-1127. doi: 10.1200/JCO.2017.75.2501. Epub 2018 Feb 28.

24.

Introductory Overview of the Natural Experiments for Translation in Diabetes 2.0 (NEXT-D2) Network: Examining the Impact of US Health Policies and Practices to Prevent Diabetes and Its Complications.

Duru OK, Mangione CM, Rodriguez HP, Ross-Degnan D, Wharam JF, Black B, Kho A, Huguet N, Angier H, Mayer V, Siscovick D, Kraschnewski JL, Shi L, Nauman E, Gregg EW, Ali MK, Thornton P, Clauser S.

Curr Diab Rep. 2018 Feb 5;18(2):8. doi: 10.1007/s11892-018-0977-5. Review.

25.

Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study.

Wharam JF, Zhang F, Eggleston EM, Lu CY, Soumerai SB, Ross-Degnan D.

Diabetes Care. 2018 May;41(5):940-948. doi: 10.2337/dc17-1183. Epub 2018 Jan 30.

26.

Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.

Adams AS, Madden JM, Zhang F, Lu CY, Ross-Degnan D, Lee A, Soumerai SB, Gilden D, Chawla N, Griggs JJ.

Value Health. 2017 Dec;20(10):1345-1354. doi: 10.1016/j.jval.2017.05.023. Epub 2017 Jul 6.

27.

Long-Term Impact of a Postdischarge Community Health Worker Intervention on Health Care Costs in a Safety-Net System.

Galbraith AA, Meyers DJ, Ross-Degnan D, Burns ME, Vialle-Valentin CE, Larochelle MR, Touw S, Zhang F, Rosenthal M, Balaban RB.

Health Serv Res. 2017 Dec;52(6):2061-2078. doi: 10.1111/1475-6773.12790.

28.

Retrospective interrupted time series examining hypertension and diabetes medicines usage following changes in patient cost sharing in the 'Farmácia Popular' programme in Brazil.

Emmerick ICM, Campos MR, Luiza VL, Chaves LA, Bertoldi AD, Ross-Degnan D.

BMJ Open. 2017 Nov 3;7(11):e017308. doi: 10.1136/bmjopen-2017-017308.

29.

Clinician-Level Predictors for Ordering Low-Value Imaging.

Hong AS, Ross-Degnan D, Zhang F, Wharam JF.

JAMA Intern Med. 2017 Nov 1;177(11):1577-1585. doi: 10.1001/jamainternmed.2017.4888.

30.

A group randomized trial using an appointment system to improve adherence to ART at reproductive and child health clinics implementing Option B+ in Tanzania.

Ross-Degnan D, Chalker J, Liana J, Kajoka MD, Valimba R, Kimatta S, Dillip A, Vialle-Valentin C, Embrey M, Lieber R, Johnson K.

PLoS One. 2017 Sep 28;12(9):e0184591. doi: 10.1371/journal.pone.0184591. eCollection 2017.

31.

Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines.

Silva RMD, Chaves GC, Chaves LA, Campos MR, Luiza VL, Bertoldi AD, Ross-Degnan D, Emmerick ICM.

Cien Saude Colet. 2017 Aug;22(8):2501-2512. doi: 10.1590/1413-81232017228.01442017.

32.

An Interrupted Time Series Analysis to Determine the Effect of an Electronic Health Record-Based Intervention on Appropriate Screening for Type 2 Diabetes in Urban Primary Care Clinics in New York City.

Albu JB, Sohler N, Li R, Li X, Young E, Gregg EW, Ross-Degnan D.

Diabetes Care. 2017 Aug;40(8):1058-1064. doi: 10.2337/dc16-2133. Epub 2017 Jun 15.

33.

Impact of a Patient Navigator Program on Hospital-Based and Outpatient Utilization Over 180 Days in a Safety-Net Health System.

Balaban RB, Zhang F, Vialle-Valentin CE, Galbraith AA, Burns ME, Larochelle MR, Ross-Degnan D.

J Gen Intern Med. 2017 Sep;32(9):981-989. doi: 10.1007/s11606-017-4074-2. Epub 2017 May 18.

34.

Small Decline In Low-Value Back Imaging Associated With The 'Choosing Wisely' Campaign, 2012-14.

Hong AS, Ross-Degnan D, Zhang F, Wharam JF.

Health Aff (Millwood). 2017 Apr 1;36(4):671-679. doi: 10.1377/hlthaff.2016.1263.

PMID:
28373333
35.

Diabetes Outpatient Care and Acute Complications Before and After High-Deductible Insurance Enrollment: A Natural Experiment for Translation in Diabetes (NEXT-D) Study.

Wharam JF, Zhang F, Eggleston EM, Lu CY, Soumerai S, Ross-Degnan D.

JAMA Intern Med. 2017 Mar 1;177(3):358-368. doi: 10.1001/jamainternmed.2016.8411.

36.

Essential medicines for universal health coverage.

Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR.

Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8. Review. No abstract available.

PMID:
27832874
37.

Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania's Health System.

Embrey M, Vialle-Valentin C, Dillip A, Kihiyo B, Mbwasi R, Semali IA, Chalker JC, Liana J, Lieber R, Johnson K, Rutta E, Kimatta S, Shekalaghe E, Valimba R, Ross-Degnan D.

PLoS One. 2016 Nov 8;11(11):e0164332. doi: 10.1371/journal.pone.0164332. eCollection 2016.

38.

Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.

Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF.

Breast Cancer Res Treat. 2016 Nov;160(2):385. No abstract available.

39.

Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose.

Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF.

Ann Intern Med. 2016 Sep 6;165(5):376-7. doi: 10.7326/L16-0168. No abstract available.

PMID:
27595218
40.

Impact of Massachusetts Health Reform on Enrollment Length and Health Care Utilization in the Unsubsidized Individual Market.

Garabedian LF, Ross-Degnan D, Soumerai SB, Choudhry NK, Brown JS.

Health Serv Res. 2017 Jun;52(3):1118-1137. doi: 10.1111/1475-6773.12532. Epub 2016 Jul 25.

41.

Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.

Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF.

Breast Cancer Res Treat. 2016 Jul;158(2):333-40. doi: 10.1007/s10549-016-3875-z. Epub 2016 Jun 24. Erratum in: Breast Cancer Res Treat. 2016 Nov;160(2):385.

42.

Variation in Postpartum Glycemic Screening in Women With a History of Gestational Diabetes Mellitus.

Eggleston EM, LeCates RF, Zhang F, Wharam JF, Ross-Degnan D, Oken E.

Obstet Gynecol. 2016 Jul;128(1):159-67. doi: 10.1097/AOG.0000000000001467.

43.

Colorectal Cancer Screening in a Nationwide High-deductible Health Plan Before and After the Affordable Care Act.

Wharam JF, Zhang F, Landon BE, LeCates R, Soumerai S, Ross-Degnan D.

Med Care. 2016 May;54(5):466-73. doi: 10.1097/MLR.0000000000000521.

PMID:
27078821
44.

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.

Sruamsiri R, Wagner AK, Ross-Degnan D, Lu CY, Dhippayom T, Ngorsuraches S, Chaiyakunapruk N.

BMJ Open. 2016 Mar 17;6(3):e008671. doi: 10.1136/bmjopen-2015-008671.

45.

Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study.

Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF.

Ann Intern Med. 2016 Jan 5;164(1):1-9. doi: 10.7326/M15-0038. Epub 2015 Dec 29.

PMID:
26720742
46.

Impacts of a new insurance benefit with capitated provider payment on healthcare utilization, expenditure and quality of medication prescribing in China.

Sun J, Zhang X, Zhang Z, Wagner AK, Ross-Degnan D, Hogerzeil HV.

Trop Med Int Health. 2016 Feb;21(2):263-74. doi: 10.1111/tmi.12636. Epub 2015 Dec 1.

47.

Barriers in household access to medicines for chronic conditions in three Latin American countries.

Emmerick IC, Luiza VL, Camacho LA, Vialle-Valentin C, Ross-Degnan D.

Int J Equity Health. 2015 Oct 31;14:115. doi: 10.1186/s12939-015-0254-z.

48.

Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management.

Garabedian LF, Ross-Degnan D, Wharam JF.

Curr Diab Rep. 2015 Dec;15(12):109. doi: 10.1007/s11892-015-0680-8. Review.

49.

What roles do accredited drug dispensing outlets in Tanzania play in facilitating access to antimicrobials? Results of a multi-method analysis.

Chalker JC, Vialle-Valentin C, Liana J, Mbwasi R, Semali IA, Kihiyo B, Shekalaghe E, Dillip A, Kimatta S, Valimba R, Embrey M, Lieber R, Rutta E, Johnson K, Ross-Degnan D.

Antimicrob Resist Infect Control. 2015 Aug 20;4:33. doi: 10.1186/s13756-015-0075-2. eCollection 2015.

50.

Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.

Hsu JC, Cheng CL, Ross-Degnan D, Wagner AK, Zhang F, Kao Yang YH, Liu LL, Tai HY, Chen KH, Yang PW, Lu CY.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1026-35. doi: 10.1002/pds.3834. Epub 2015 Aug 6.

Supplemental Content

Loading ...
Support Center